Kenfarb & Co’s CareTrust REIT CTRE Stock Holding History

Kenfarb & Co’s Portfolio CTRE Stock Details CTRE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-14,418	Closed	-$329K	–	170
2021 Q4	$329K	Buy	+14,418	New	+$305K	0.24%	86

Other funds holding CTRE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Kenfarb & Co's CTRE Position: Q1 2022 in Review

Kenfarb & Co sold out of CareTrust REIT (CTRE) in Q1 2022, closing a stake of 14,418 shares — an estimated $329K sold.

Kenfarb & Co first reported a position in CTRE in Q4 2021 and held it in 1 quarter. The position peaked at $329K in Q4 2021. 241 funds tracked by Wall St. Rank hold CTRE as of Q1 2022.

Kenfarb & Co reported no remaining CareTrust REIT position as of Q1 2022 after selling out during the quarter.
Kenfarb & Co sold 14,418 CareTrust REIT shares in Q1 2022, an estimated $329K.
Kenfarb & Co first reported a position in CareTrust REIT in Q4 2021 and held it in 1 quarter.
Kenfarb & Co's CareTrust REIT position peaked at $329K in Q4 2021.
241 funds tracked by Wall St. Rank held CareTrust REIT as of Q1 2022.

Based on Kenfarb & Co's 13F filing for Q1 2022, filed 16 May 2022.